首页 › 基金 › SHENKMAN CAPITAL MANAGEMENT INC › VKTX
SHENKMAN CAPITAL MANAGEMENT INC 对 VKTX 的持仓历史
VIKING THERAPEUTICS INC · 医疗保健
SHENKMAN CAPITAL MANAGEMENT INC 在 Q3 2026 的 13F 申报中披露持有 VKTX(VIKING THERAPEUTICS INC)2,500,000 股,市值约 US$2.5M,约占其申报组合的 0.52%,在其申报持仓中市值排名第 38 位。 SHENKMAN CAPITAL MANAGEMENT INC 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
SHENKMAN CAPITAL MANAGEMENT INC 对 VKTX 的持仓演变
SHENKMAN CAPITAL MANAGEMENT INC 于 Q3 2026 首次披露 VKTX 持仓:2,500,000 股(约 US$2.5M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 2.50M | $2.55M | 新进 |
关于 VKTX 与 13F 数据
VKTX(VIKING THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 32 只申报持有 VKTX,申报仓位最大的包括:Context Capital Management, LLC (US$39.9M), Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 VKTX 的基金
- Context Capital Management, LLC 40.00M 股 · $39.91M · Q3 2026
- Vestal Point Capital, LP 680.00K 股 · $26.53M · Q2 2026
- Eversept Partners, LP 602.92K 股 · $23.52M · Q2 2026
- ADAR1 Capital Management, LLC 574.04K 股 · $22.39M · Q2 2026
更多关于 SHENKMAN CAPITAL MANAGEMENT INC
常见问题
How long has SHENKMAN CAPITAL MANAGEMENT INC held VKTX?
SHENKMAN CAPITAL MANAGEMENT INC has disclosed VKTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is SHENKMAN CAPITAL MANAGEMENT INC's current position in VKTX?
As of Q3 2026, SHENKMAN CAPITAL MANAGEMENT INC holds 2.50M shares of VKTX (VIKING THERAPEUTICS INC), valued at $2.55M, representing 0.52% of its reported portfolio and ranking #38.
Has SHENKMAN CAPITAL MANAGEMENT INC been buying or selling VKTX?
In the latest 13F filing (Q3 2026), SHENKMAN CAPITAL MANAGEMENT INC newly opened its position in VKTX.
Which other funds hold VKTX?
Other major institutional holders of VKTX include Context Capital Management, LLC, Vestal Point Capital, LP, Eversept Partners, LP, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.